|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1991 Founded as Paradigm Biosciences
Initial research
focused on development of DHEA for acute inflammation.
1996 Changed name to Pharmadigm
Developed oral and
IV formulations of DHEA.
2004 Changed name to Inflabloc Pharmaceuticals
Initiates development of fixed combination drug products that incorporate DHEA as a primary active ingredient.
 |
 |
|
 |
|
|
